MedPath

Whether herbal eye drops help in management of dry eye syndrome ?

Phase 4
Not yet recruiting
Conditions
Patients with sign and symptoms of shuskakshipaaka (dry eye syndrome)
Registration Number
CTRI/2018/03/012530
Lead Sponsor
All india Institute of Ayurveda
Brief Summary

This study is an open label double arm randomised clinical trial comparing the efficacy of Rajnidaaru eye drops (2drop in each eye)along with Rasayan Churna(3g BD) and alone for 42 days in patients of shuskakshipaaka (Dry eye syndrome) for 30 days.The trail will be conducted in All India institute of Ayurveda.The primary outcome measures will be reduction in th clinical features of dry eye syndrome and the secondary outcomes will be changes in quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria
  • 1.Patients of either sex aged up to18.
  • 60 years. 2.Patients presenting with signs and symptoms of Dry eye syndrome. 3.Willing and able to participate in the study.
Exclusion Criteria
  • 1.Age group less than 18 and more than 60 years.
  • 2.Severe cases of dry eye syndrome with complications like perforated corneal ulcer, Uveitis, Glaucoma.
  • 3.Allergic eye disease i.e. vernal keratoconjunctivitis, Giant papillary conjunctivitis.
  • 4.Non specific topical beta blocker users.
  • 5.Inflammatory conditions like acute conjunctivitis.
  • 6.Patients on steroids, oral contraceptive pills, estrogen replacement therapy or any other medication such as antispasmodic drugs like Atropine that may adversely affect the outcome of the study.
  • 7.Patients suffering from major systemic illness necessitating long term drug treatment i.e. Psycho-epileptic drug users.
  • 8.H/o hypersensitivity to the trial drug or any of its ingredients.
  • 9.Persistent Contact Lens Users.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in clinical features of dry eye syndromeThe patients will be assesed at the end of the study
Secondary Outcome Measures
NameTimeMethod
Changes in the quality of lifeThe patients will be assesed at the end of the study

Trial Locations

Locations (1)

AIIA

🇮🇳

West, DELHI, India

AIIA
🇮🇳West, DELHI, India
Dr Manjusha Rajagopala
Principal investigator
7600901848
bhatrajma2008@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.